The New York Times, January 2, 2026 (interviewed by Carl Zimmer)
Brenna Henn: In my lab, we’re interested in characterizing human diversity, especially from populations that live in Africa or are descendants from Africa. One thing we wanted to address is the huge focus on personalized genetic medicine. The idea is that you get your genome sequenced, and then for heart disease or tuberculosis — pick your favorite disease — we’ll be able to give you a score of how likely you’ll be to develop these things.